| Roche Pharma (Schweiz) AG - Cellcept i.v., Lyophilisat zur Herstellung einer Infusionslösung |
| 54688 | | 01 | | Cellcept i.v. | | Lyophilisat zur Herstellung einer Infusionslösung | | L04AA06 | | Mycophenolic Acid | | 31.08.1998 | | |
|
| Composition |
| Praeparatio cryodesiccata: mofetili mycophenolas 500 mg, polysorbatum 80, acidum citricum, natrii chloridum, pro vitro. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | Lyophilisate | | | | | | Active Agent | Dose |
|---|
| Mofetil Mycophenolate | 500 mg |
| | | | Inactive agents |
|---|
| Citric Acid | | Sodium Chloride | | Polysorbatum 80 |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 016 | 4 Durchstechflasche(n) | | 184.30 | B | | No |
|
